This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...

Oncologist Dr Satheesh warns of rising lung cancer cases among non-smokers in India, attributing it to pollution and indoor smoke.

Doctors warn that breast cancer is rising among women under 40, with aggressive subtypes becoming more common. Experts urge ...

Is breast cancer only an older woman's disease? Can men get it? Is pain a sign? Experts bust myths about mammograms, bras, ...

Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...

Panelists discuss how EGFR mutation profiling guides targeted first-line NSCLC therapy and shifts care toward precision medicine. Panelists discuss how understanding EGFR mutations has transformed the ...

Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...

A research team from The University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered a new molecular mechanism underlying chromosome alignment during cell ...

Biomedical engineers at Duke University have shown that a genetic mutation that causes congenital heart disease also ...

Sacituzumab tirumotecan significantly reduced progression or death risk by 51% compared to chemotherapy in EGFR-mutated non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors. The ...

Taiho Oncology Inc. and Cullinan Therapeutics Inc. (NASDAQ:CGEM) shared new data on Sunday from the central nervous system (CNS) involvement cohort of the REZILIENT2 study of zipalertinib for advanced ...

Eilean Therapeutics is a biopharmaceutical company focused on the development of best-in-class and first-in-class small molecule inhibitors that target escape mutations in hematologic malignancies and ...